Literature DB >> 26608523

Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome.

E Tabouret1,2, C Boucard3, R Devillier4, M Barrie3, S Boussen4, D Autran3, O Chinot3,5, N Bruder6.   

Abstract

The prognosis of oncology patients admitted to the intensive care unit (ICU) is considered poor. Our objective was to analyze the characteristics and predictive factors of death in the ICU and functional outcome following ICU treatment for neuro-oncology patients. A retrospective study was conducted on all patients with primary brain tumor admitted to our institutional ICU for medical indications. Predictive impact on the risk of death in the ICU was analyzed as well as the functional status was evaluated prior and following ICU discharge. Seventy-one patients were admitted to the ICU. ICU admission indications were refractory seizures (41 %) and septic shock (17 %). On admission, 16 % had multi-organ failure. Ventilation was necessary for 41 % and catecholamines for 13 %. Twenty-two percent of patients died in the ICU. By multivariate analysis, predictive factors associated with an increased risk of ICU death were: non-neurological cause of admission [p = 0.045; odds ratio (OR) 5.405], multiple organ failure (p = 0.021; OR 8.027), respiratory failure (p = 0.006; OR 9.615), and hemodynamic failure (p = 0.008; OR 10.111). In contrast, tumor type (p = 0.678) and disease control status (p = 0.380) were not associated with an increased risk of ICU death. Among the 35 evaluable patients, 77 % presented with a stable or improved Karnofsky performance status following ICU hospitalization compared with the ongoing status before discharge. In patients with primary brain tumor admitted to the ICU, predictive factors of death appear to be similar to those described in non-oncology patients. ICU hospitalization is generally not associated with a subsequent decrease in the functional status.

Entities:  

Keywords:  Glioma; Intensive care; Neuro-oncology; Primary cerebral lymphoma

Mesh:

Year:  2015        PMID: 26608523     DOI: 10.1007/s11060-015-2015-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

Review 1.  Critically ill cancer patient in intensive care unit: issues that arise.

Authors:  Eirini Kostakou; Nikoletta Rovina; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Antonia Koutsoukou
Journal:  J Crit Care       Date:  2014-04-24       Impact factor: 3.425

2.  Intensive care in patients with lung cancer: a multinational study.

Authors:  M Soares; A-C Toffart; J-F Timsit; G Burghi; C Irrazábal; N Pattison; E Tobar; B F C Almeida; U V A Silva; L C P Azevedo; A Rabbat; C Lamer; A Parrot; V C Souza-Dantas; F Wallet; F Blot; G Bourdin; C Piras; J Delemazure; M Durand; D Tejera; J I F Salluh; E Azoulay
Journal:  Ann Oncol       Date:  2014-06-20       Impact factor: 32.976

3.  Outcomes and prognostic factors of patients with lung cancer and pneumonia-induced respiratory failure in a medical intensive care unit: a single-center study.

Authors:  Youjin Chang; Jin-Won Huh; Sang-Bum Hong; Dae Ho Lee; Cheolwon Suh; Sang-We Kim; Chae-Man Lim; Younsuck Koh
Journal:  J Crit Care       Date:  2014-01-13       Impact factor: 3.425

4.  Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU.

Authors:  B Lamia; M-F Hellot; C Girault; F Tamion; F Dachraoui; P Lenain; G Bonmarchand
Journal:  Intensive Care Med       Date:  2006-08-01       Impact factor: 17.440

5.  Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study.

Authors:  Guillaume Thiéry; Elie Azoulay; Michael Darmon; Magali Ciroldi; Sandra De Miranda; Vincent Lévy; Fabienne Fieux; Delphine Moreau; Jean Roger Le Gall; Benoît Schlemmer
Journal:  J Clin Oncol       Date:  2005-07-01       Impact factor: 44.544

6.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

Authors:  Olivier L Chinot; Wolfgang Wick; Warren Mason; Roger Henriksson; Frank Saran; Ryo Nishikawa; Antoine F Carpentier; Khe Hoang-Xuan; Petr Kavan; Dana Cernea; Alba A Brandes; Magalie Hilton; Lauren Abrey; Timothy Cloughesy
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

7.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

8.  Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

Authors:  Carole Soussain; Khê Hoang-Xuan; Luc Taillandier; Emmanuelle Fourme; Sylvain Choquet; Francis Witz; Olivier Casasnovas; Brigitte Dupriez; Bertrand Souleau; Anne-Laure Taksin; Christian Gisselbrecht; Arnaud Jaccard; Antonio Omuro; Marc Sanson; Maud Janvier; Brigitte Kolb; Jean-Marc Zini; Véronique Leblond
Journal:  J Clin Oncol       Date:  2008-04-14       Impact factor: 44.544

9.  Outcomes in critically ill cancer patients with septic shock of pulmonary origin.

Authors:  Etienne de Montmollin; Yacine Tandjaoui-Lambiotte; Mattieu Legrand; Jérôme Lambert; Djamel Mokart; Achille Kouatchet; Virginie Lemiale; Frédéric Pène; Fabrice Bruneel; François Vincent; Julien Mayaux; Sylvie Chevret; Elie Azoulay
Journal:  Shock       Date:  2013-03       Impact factor: 3.454

10.  A prospective audit of costs of intensive care in cancer patients in India.

Authors:  Atul P Kulkarni; Jigeeshu V Divatia
Journal:  Indian J Crit Care Med       Date:  2013-09
View more
  4 in total

1.  Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience.

Authors:  Maxens Decavèle; Nicolas Weiss; Isabelle Rivals; Hélène Prodanovic; Ahmed Idbaih; Julien Mayaux; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2017-10-09       Impact factor: 4.849

2.  Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience.

Authors:  Maxens Decavèle; Aliénor Dreyfus; Nicolas Gatulle; Nicolas Weiss; Caroline Houillier; Sophie Demeret; Julien Mayaux; Isabelle Rivals; Martin Dres; Julie Delemazure; Elise Morawiec; Charles-Edouard Luyt; Khe Hoang-Xuan; Sylvain Choquet; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2021-01-16       Impact factor: 4.849

3.  Non-convulsive seizures in the encephalopathic critically ill cancer patient does not necessarily portend a poor prognosis.

Authors:  Cristina Gutierrez; Merry Chen; Lei Feng; Sudhakar Tummala
Journal:  J Intensive Care       Date:  2019-12-16

4.  One-year survival of patients with high-grade glioma discharged alive from the intensive care unit.

Authors:  Maxens Decavèle; Nicolas Gatulle; Nicolas Weiss; Isabelle Rivals; Ahmed Idbaih; Sophie Demeret; Julien Mayaux; Martin Dres; Elise Morawiec; Khe Hoang-Xuan; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2020-08-29       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.